Home NDC 0053-7213 NDC 0053-7213 - Zemaira This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 0053-7213
Package NDCs from labels 0053-7213-01
Manufacturer CSL Behring LLC
Effective date 2024-09-23
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type Zemaira - CSL Behring LLC CSL Behring LLC 2024-09-23 PLASMA DERIVATIVE
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0053-7213-01 ZEMAIRA 95 mL in 1 VIAL, SINGLE-USE INJECTION, POWDER, LYOPHILIZED, 95 mL 5000 mg in 95mL 27
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0053-7213 ZEMAIRA (ALPHA-1-PROTEINASE INHIBITOR HUMAN) KIT ZEMAIRA (.ALPHA.1-PROTEINASE INHIBITOR HUMAN) KIT [CSL BEHRING LLC] 27 Unmatched 20240926_0c3354b5-a1d8-4f98-ad55-2eafe4265c4e.zip
DailyMed Socrata Ingredients#